Portfolio comparison
Novartis AG vs Kirin Amgen Inc
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Top Patents2 enriched
US 10472419· 2019
How Novartis Engineered Antibodies to Block the TIM-3 Immune Checkpoint
US 7740842· 2010
How to Keep High-Concentration Antibody Medicines Stable in Liquid Form
Activity by Decade
2010s2
Company B
Kirin Amgen Inc
Patents indexed
1
Year range
1987
Most recent
1987
biotechpharmaceuticalgene_editingbiotechnology
Top Patents1 enriched
US 4703008· 1987
How to Make Human Erythropoietin (EPO) Using Engineered DNA
Activity by Decade
1980s1
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.